A delay in diagnosis can be risky for infants admitted to NICUs or PICUs. Many such cases are due to genetic disorders, and early identification is crucial for proper treatment. Genetic testing, like the rapid exome sequencing, can play a significant role in accelerating and guiding the treatment procedure.
Genetic testing directly impacts treatment management and interventional decisions in 44-88% of patients with confirmed molecular diagnoses. With a timely diagnosis, doctors can avoid unnecessary or invasive tests and focus on the right treatment from the beginning. This not only helps in faster recovery but also reduces long-term complications for the child.














